Cargando…

Evolution of tuberculosis/HIV co-infection in California during the HAART Era, 1996-2007

Detalles Bibliográficos
Autores principales:	Metcalfe, John, Facer, Matt, Damesyn, Mark, Xia, Qiang, Watt, James, Hill, Julia, Hopewell, Philip, Westenhouse, Janice, Flood, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316054/ http://dx.doi.org/10.1186/1742-4690-7-S1-O1

Ejemplares similares

Tuberculosis and HIV Co-infection, California, USA, 1993–2008
por: Metcalfe, John Z., et al.
Publicado: (2013)

1392. Tuberculosis Disease in Recipients of Organ-Transplantation, California 2010–2017
por: Katrak, Shereen, et al.
Publicado: (2019)

Determinants of Multidrug-Resistant Tuberculosis Clusters, California, USA, 2004–2007
por: Metcalfe, John Z., et al.
Publicado: (2010)

Assessing the validity of tuberculosis surveillance data in California
por: Sprinson, Joan E, et al.
Publicado: (2006)

Interferon-γ Release Assay Performance in Pediatric Tuberculosis Disease in California
por: Kay, Alexander, et al.
Publicado: (2017)

Trends in cancer incidence among HIV-infected persons in California, 1996–2006
por: Silverberg, MJ, et al.
Publicado: (2009)

Risk of death among Italian AIDS cases with AIDS-defining cancers in the post-HAART era
por: Serraino, D, et al.
Publicado: (2009)

Getting to Zero: Tuberculosis Elimination in California
por: Barry, Pennan M., et al.
Publicado: (2016)

Neurodegeneration in the HAART era
por: Brew, Bruce J
Publicado: (2010)

HIV/HAART and the brain — what's going on?
por: Portegies, P
Publicado: (2010)

Regional Differences Among HIV Patients in Care: California Medical Monitoring Project Sites, 2007-2008
por: Scheer, Susan, et al.
Publicado: (2012)

When Tuberculosis Comes Back: Who Develops Recurrent Tuberculosis in California?
por: Pascopella, Lisa, et al.
Publicado: (2011)

Prevalence of tuberculosis in HIV in Ethiopia in early HAART era: retrospective analysis
por: Gudina, Esayas Kebede, et al.
Publicado: (2013)

Semen may harbor HIV despite effective HAART: another piece in the puzzle
por: Halfon, Philippe, et al.
Publicado: (2010)

Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
por: Bourry, Olivier, et al.
Publicado: (2009)

Oral lesions among HIV seropositive individuals in an era of generic HAART: markers of HAART efficacy?
por: Vasudevan, Janani, et al.
Publicado: (2012)

HAART rollout in the new fiscal and economic environment
por: Moatti, J
Publicado: (2012)

Immune-based therapy using gamma interferon ingaron in the treatment of HIV/AIDS patients with active pulmonary tuberculosis (PTB) not previously highly active antiretroviral therapy (HAART)
por: Yola, Auwal, et al.
Publicado: (2006)

The EuResist expert model for customised HAART optimisation: 2010 update and extension to newest compounds
por: Pironti, A, et al.
Publicado: (2010)

Death With Tuberculosis in California, 1994–2008
por: Pascopella, Lisa, et al.
Publicado: (2014)

Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019
por: Brandal, Lin T., et al.
Publicado: (2022)

History of HAART – the true story of how effective multi-drug therapy was developed for treatment of HIV disease
por: Delaney, Martin
Publicado: (2006)

Neutralizing anti-Tat antibodies prolonged HAART interruption in vaccines in a prospective structured interruption study
por: Clumeck, Nathan, et al.
Publicado: (2006)

The value and implementation of routine ophthalmic examination in the era of HAART
por: Li, Wangting, et al.
Publicado: (2020)

Gastric Bypass Surgeries in New Hampshire, 1996-2007
por: Cherala, Sai S.
Publicado: (2012)

Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART
por: Rusconi, S, et al.
Publicado: (2010)

Tenofovir (TDF) containing first-line HAART is associated with changes in plasma parameters suggestive of increased bone resorption
por: Labarga, Pablo, et al.
Publicado: (2010)

Cost-Effectiveness of Early Treatment with First-Line NNRTI-Based HAART Regimens in the UK, 1996-2006
por: Beck, Eduard J., et al.
Publicado: (2011)

HAART and ATT in the HIV-positive patient with tuberculosis
por: Jhiens, Zi Z., et al.
Publicado: (2012)

Estimated HIV Incidence in California, 2006–2009
por: Scheer, Susan, et al.
Publicado: (2013)

Measurements of total and integrated HIV DNA demonstrate sporadic blips of unintegrated HIV DNA in HIV-positive patients on HAART
por: Mexas, A, et al.
Publicado: (2010)

Monitoring of the Polish Mental Health Act implementation in the years 1996–2005
por: Brodniak, Wlodzimierz, et al.
Publicado: (2007)

Adjustable gravitational valves. From the conception in 1996 to first implantations 2008
por: Aschoff, Alfred, et al.
Publicado: (2009)

Assessing Complexity Among Patients With Tuberculosis in California, 1993–2016
por: Vaisman, Alon, et al.
Publicado: (2020)

Ophthalmic manifestations of human immunodeficiency virus infection: Pre- highly active antiretroviral chemotherapy (HAART) and post- HAART era
por: Sinha, Rajesh, et al.
Publicado: (2008)

Pattern of cancer risk in persons with AIDS in Italy in the HAART era
por: Dal Maso, L, et al.
Publicado: (2009)

Emergency department utilization by HIV-positive adults in the HAART era
por: Venkat, Arvind, et al.
Publicado: (2008)

The Impact of HIV on Maternal Morbidity in the Pre-HAART Era in Uganda
por: Nuwagaba-Biribonwoha, Harriet, et al.
Publicado: (2012)

Intensive Care Usage by HIV-Positive Patients in the HAART Era
por: Turtle, L., et al.
Publicado: (2011)

Human Polyomavirus-Associated Cerebral Disorders in the Post-HAART Era
por: Cedeno-Laurent, Filiberto, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_sq7vjr9g16c84oviil4ge2flic